Estimated Effectiveness of Postpartum Maternal Messenger RNA COVID-19 Vaccination Against Delta and Omicron SARS-CoV-2 Infection and Hospitalization in Infants Younger Than 6 Months

This case-control study estimates the effectiveness of maternal postpartum messenger RNA (mRNA) COVID-19 vaccination against Delta and Omicron SARS-CoV-2 infection and hospitalization in infants younger than 6 months.

Detalles Bibliográficos
Autores principales: Jorgensen, Sarah C. J., Hernandez, Alejandro, Fell, Deshayne B., Austin, Peter C., D’Souza, Rohan, Guttmann, Astrid, Kwong, Jeffrey C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972229/
https://www.ncbi.nlm.nih.gov/pubmed/36848130
http://dx.doi.org/10.1001/jamapediatrics.2022.6134
Descripción
Sumario:This case-control study estimates the effectiveness of maternal postpartum messenger RNA (mRNA) COVID-19 vaccination against Delta and Omicron SARS-CoV-2 infection and hospitalization in infants younger than 6 months.

Ejemplares similares